Transitional cell carcinoma

Common Name(s)

Transitional cell carcinoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Transitional cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Transitional cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Transitional cell carcinoma" returned 624 free, full-text research articles on human participants. First 3 results:

VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland.
 

Author(s): Syed A Hussain, Jawaher Ansari, Robert Huddart, Derek G Power, Jeanette Lyons, James Wylie, Maria Vilarino-Varlela, Nils O Elander, Rhona McMenemin, Lisa M Pickering, Guy Faust, Seema Chauhan, Richard J Jackson

Journal: Int. J. Oncol.. 2017 Mar;50(3):768-772.

 

There is no standard of care in the UK or Ireland for second-line chemotherapy for patients with advanced transitional cell carcinoma (TCCU). Vinflunine is approved for TCCU patients who have failed a platinum-based regimen, and is standard of care in Europe but is not routinely available ...

Last Updated: 18 Jan 2017

Go To URL
Primary Retroperitoneal Transitional Cell Carcinoma - A Rare Clinical Entity.
 

Author(s): Pramod Kumar Sharma, Rajan Kumar Sinha, Subhabrata Mukherjee

Journal:

 

Last Updated: 13 Oct 2016

Go To URL
Unusual Development of Pulmonary Tumor Embolism from Controlled Liver Metastases of Transitional Cell Carcinoma: An Autopsy Case.
 

Author(s): Hiromitsu Kitayama, Taro Yokota, Tomohiro Kondo, Junko Sugiyama, Michiaki Hirayama, Yumiko Oyamada, Yasushi Tsuji

Journal: Intern. Med.. 2016 ;55(17):2453-6.

 

Clinicians generally suspect pulmonary tumor embolism (PTE) with uncontrolled carcinomas which often spread to lungs. We, however, experienced an autopsy case of diffuse microscopic PTE despite controlled liver metastases of transitional cell carcinoma (TCC). A 66-year-old man with ...

Last Updated: 1 Sep 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Transitional cell carcinoma" returned 84 free, full-text review articles on human participants. First 3 results:

Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review.
 

Author(s): Mingyang Li, An Shi, Wen Kong, Jin Zhang, Yonghui Chen, Jiwei Huang, Yiran Huang

Journal:

 

Transitional cell carcinoma (TCC) originating from the renal pelvis with a venous tumor thrombus is a rare entity. However, clinicians should be aware of it because of its high malignancy and poor prognosis.

Last Updated: 29 Dec 2016

Go To URL
Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
 

Author(s): Min Hyun Cho, Sung Han Kim, Weon Seo Park, Jae Young Joung, Ho Kyung Seo, Jinsoo Chung, Kang Hyun Lee

Journal:

 

Sarcomatoid urothelial carcinoma (SUC) is a rare malignant neoplasm of the urinary bladder comprising 0.2-0.6 % of all histological bladder tumor subtypes. It presents as a high-stage malignancy and exhibits aggressive biological behavior, regardless of the treatment employed. It ...

Last Updated: 21 Oct 2016

Go To URL
Transurethral Resection of the Bladder Tumour as a Treatment Method in Children with Transitional Cell Carcinoma of the Bladder--Analysis of Our Material and Literature Review.
 

Author(s): Wojciech Apoznański, Jolanta Rysiakiewicz, Marcin Polok, Konrad Rysiakiewicz, Piotr Siekanowicz, Tomasz Hilger, Jan Zagierski, Magdalena Hilger, Irena Nowak, Piotr Kolęda, Tomasz Szydełko

Journal: Adv Clin Exp Med. ;24(3):505-9.

 

Bladder cancer occurs mainly in adults. In children, younger than 10 years in particular, it is very rare.

Last Updated: 15 Oct 2015

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Detecting Transitional Cell Carcinoma From Haematuria
 

Status: Recruiting

Condition Summary: Transitional Cell Carcinoma

 

Last Updated: 17 Aug 2017

Go to URL
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
 

Status: Recruiting

Condition Summary: Transitional Cell Carcinoma; Advanced Cancer; Metastatic Cancer

 

Last Updated: 8 Aug 2017

Go to URL
Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
 

Status: Recruiting

Condition Summary: Transitional Cell Carcinoma

 

Last Updated: 16 Nov 2017

Go to URL